CYP2C19 Genotype and Cardiovascular Events Reply

被引：1
|
作者：
Nissen, Steven E. [1 ]
机构：
[1] Cleveland Clin Fdn, Div Cardiovasc Med, Cleveland, OH 44195 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 307卷 / 14期
关键词：
RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; ESTROGEN; RISK;
D O I：
10.1001/jama.2012.447
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1485 / 1485
页数：1
相关论文
共 50 条
  • [21] DISTRIBUTION OF THE CYP2C19*2, CYP2C19*3 AND CYP2C19*4 GENE VARIANTS IN A ROMANIAN POPULATION
    Buzoianu, A. D.
    Trifa, A. P.
    Popp, R. A.
    Militaru, C. F.
    Bocsan, C., I
    Popp, I., V
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 80 - 80
  • [22] The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir
    Burger, David M.
    Schwietert, H. Reinier
    Colbers, E. P. H. Angela
    Becker, Mark
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (02) : 250 - 252
  • [23] THE IMPACT OF CYP2C19 GENOTYPE ON ENDOTHELIAL FUNCTION, ARTERIAL STIFFNESS AND CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE RECEIVING CLOPIDOGREL
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Zaromitidou, Marina
    Oikonomou, Evangelos
    Maniatis, Konstantinos
    Kioufis, Stamatis
    Kokkou, Eleni
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E2116 - E2116
  • [24] CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population
    Dogan, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 12 - 12
  • [25] Evaluation of a CYP2C19 genotype panel on the GenMark eSensor® platform and the comparison to the Autogenomics Infiniti™ and Luminex CYP2C19 panels
    Lee, Christine C.
    McMillin, Gwendolyn A.
    Babic, Nikolina
    Melis, Roberta
    Yeo, Kiang-Teck J.
    CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 1133 - 1137
  • [26] Protective effect of the CYP2C19*17 polymorphism with increased activation of clopidogrel on cardiovascular events
    Tiroch, Klaus A.
    Sibbing, Dirk
    Koch, Werner
    Roosen-Runge, Tobias
    Mehilli, Julinda
    Schoemig, Albert
    Kastrati, Adnan
    AMERICAN HEART JOURNAL, 2010, 160 (03) : 506 - 512
  • [27] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [28] REPLY: Precision Antiplatelet Therapy for CYP2C19 Genotype Variants for Achieving Better Clinical Outcomes
    Pereira, Naveen L.
    Rihal, Charanjit S.
    Farkouh, Michael E.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (13) : 1501 - 1501
  • [29] Relationship of CYP2C19*2 and CYP2C19*3 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention
    Liu, Yamin
    Liu, Naifeng
    Li, Weilan
    Shao, Hua
    Zhi, Hong
    Li, Jie
    PHARMACOLOGY, 2013, 91 (3-4) : 165 - 172
  • [30] Association between CYP2C19 genotype and proguanil oxidative polymorphism
    Coller, JK
    Somogyi, AA
    Bochner, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) : 659 - 660
12345